Tela Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -26.1% | +45.3% | +6.4% | +5.6% | +1.1% | +0.4% | +1.1% | -8.1% | -9.3% | +17.3% | +0.8% | – | |
| – | -9.3% | -11.2% | -1.1% | -0.8% | +0.7% | -4.1% | -5.7% | -3.0% | -15.0% | +0.5% | -24.9% | – | |
| – | -99.0% | -15,185.7% | – | -1,022.2% | – | – | – | +44.1% | +116.4% | -205.4% | – | – | |
| – | +53.0% | +48.3% | -1.6% | -59.2% | +116.4% | -87.9% | +256.3% | +85.1% | -56.9% | +30.8% | -50.4% | – | |
| – | +44.0% | – | -98.6% | -282.1% | +55.7% | – | +47.8% | +52.9% | -38.5% | -1.0% | +25.8% | – | |
| – | -20.0% | +8,100.0% | -96.6% | +72.7% | -42.1% | – | – | – | -213.9% | – | -448.1% | – | |
| – | -69.0% | +154.5% | -108.9% | – | +43,683.7% | -100.3% | -97.4% | – | +107,587.5% | -101.2% | -95.0% | – | |
| – | – | – | – | – | – | -127.8% | – | – | – | -153.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.